Florida, USA-based biotech GOA Therapeutics has launched offerings totaling $300 million to fund the advancement of its drug ...
US healthcare giant Johnson & Johnson has announced new data that further expands the clinical evidence supporting Tremfya ...
The US Food and Drug Administration (FDA) yesterday approved UK pharma major GSK’s Hibsago (bepirovirsen) injection, in ...
Russian pharmaceutical manufacturers and global drugmakers operating in the local market have called on the need of ...
US artificial intelligence (AI) company OpenAI has acquired Orchestra Bio, adding a platform for coordinating drug ...
US biotech Rapport Therapeutics (Nasdaq: RAPP) plans to begin two Phase III trials of RAP-219 in acute bipolar mania in the ...
ViiV Healthcare, the HIV company majority owned by GSK, today announced that Deborah Waterhouse will step down as chief ...
Takeda made Orzeyful (oveporexton) available in Japan and China for narcolepsy type 1, while Insmed launched Brinsupri ...
Median annual net drug launch prices in the USA reached $257,000 in 2025, remaining 35% above their 2022 level despite a ...
UK biotechnology Touchlight, which is specializing in cell-free DNA manufacturing, today announces that Karen Fallen is ...
The Central Drugs Standard Control Organization (CDSCO), under the Drug Controller General of India (DCGI), has granted marketing authorization to Qfitlia (fitusiran), French. Pharma major Sanofi ...
Japan’s largest drugmaker Takeda has announced new data from VERDICT showing that treating adults with intravenous Entyvio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results